David Aronoff Archives
Aronoff departing VUMC to become chair of the Department of Medicine at Indiana University School of Medicine
Aug. 11, 2021—David Aronoff, MD, Addison B. Scoville Jr. Professor of Medicine and director of the Division of Infectious Diseases, is departing Vanderbilt University Medical Center to become chair of the Department of Medicine at Indiana University School of Medicine.
American Airlines boosts travelers’ peace of mind with VUMC expertise
Jun. 26, 2020—American Airlines has created a new Travel Health Advisory Panel that includes Vanderbilt University Medical Center infectious disease experts to advise on health and cleaning matters as travelers return over the summer.
Target trials support drug safety in pregnant patients
May. 27, 2020—Out of concern for fetal safety, pregnant people have typically been excluded from drug trials. And when human health is on the line, drug studies assessing fetal safety in animal models may be viewed as far from definitive.
Ibuprofen and COVID-19: a doctor’s guidance
Mar. 18, 2020—Last week, France’s health ministry urged people who have been infected by the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) to avoid taking over-the- counter nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, naproxen and aspirin because they might increase the severity of the infection.
Treating C. diff: new purpose for an old drug?
Sep. 24, 2019—An inexpensive generic drug once used to prevent gastrointestinal ulcers in people taking daily NSAIDs protects against C. diff infection in mice.
Major grant renews AIDS education, training initiative
Jul. 24, 2019—VUMC has been awarded a five-year, nearly $23 million federal grant to continue coordinating AIDS education and training efforts in Tennessee and seven other southeastern states.
Vanderbilt team shows how stomach bug can trigger cancer
Jul. 11, 2019—Researchers at Vanderbilt University and the University of Michigan in Ann Arbor have obtained the first high-resolution image of a molecular “machine” used by the insidious stomach bug Helicobacter pylori (H. pylori) to inject a cancer-causing protein into the stomach lining.
Pain relievers a risk for C. diff?
Jan. 17, 2019—A link between anti-inflammatory drugs such as ibuprofen and C. diff infection suggests caution against overusing such drugs in patients at high risk for infection.
Fetal membranes and microbial threats
Oct. 26, 2018—Understanding how cells communicate in the membranes surrounding the developing fetus could suggest new strategies for preventing infections, premature birth and adverse pregnancy outcomes.
VUMC drug repurposing initiative gaining momentum
Apr. 19, 2018—Drug repurposing involves establishing an additional approved indication for a drug already at market.
Grant bolsters study of potential new therapy for C. diff infection
Mar. 22, 2018—According to the Centers for Disease Control and Prevention, in 2011 in the United States there were almost half a million Clostridium difficile infections, and one in 11 patients 65 or older with a healthcare-associated C. diff infection died within 30 days of diagnosis.
Aronoff elected to microbiology academy
Apr. 27, 2017—Infectious diseases specialist David Aronoff, M.D., recently became one of 73 new fellows of the American Academy of Microbiology, an honorific leadership group within the American Society of Microbiology.
